Skip to main content
. Author manuscript; available in PMC: 2018 Dec 31.
Published in final edited form as: JCO Precis Oncol. 2018 Jul 11;2018:10.1200/PO.18.00122. doi: 10.1200/PO.18.00122

Table 1:

List of Available TAPUR Study Treatments for both Adults and Pediatric Subjects

Study Drug Available to Adult (≥ 18 years)/Pediatric Population
Axitinib Adults and children aged 12–17
Bosutinib Adults only
Cetuximab Adults and children aged 12–17
Crizotinib Adults and children aged 16–17
Dasatinib Adults and children aged 13–17
Erlotinib Adults and children aged 12–17
Nivolumab plus Ipilimumab Adults only
Olaparib Adults and children aged 16–17 only
Palbociclib Adults only
Pembrolizumab Adults and children aged 12–17
Regorafenib Adults and children aged 12–17
Sunitinib Adults and children aged 12–17
Temsirolimus Adults and children aged 12–17
Trastuzumab plus Pertuzumab Adults only
Vemurafenib plus Cobimetinib Adults only
Vismodegib Adults and children aged 12–17